Quarterly report pursuant to Section 13 or 15(d)

Supplemental Information to Condensed Consolidated Statements of Cash Flows (Detail)

v3.21.2
Supplemental Information to Condensed Consolidated Statements of Cash Flows (Detail) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2021
Mar. 31, 2021
Jun. 30, 2020
Mar. 31, 2020
[3]
Jun. 30, 2021
Jun. 30, 2020
Schedule Of Cash Flow Supplemental [Line Items]            
Cash paid for interest         $ 59,890 $ 47,014
Cash paid (refunds received) for income taxes, net         (136,397) 5,229
Cash deposited in restricted accounts [1] $ 7,300       7,300  
Noncash investing and financing activities:            
Change in accounts payable and accrued expenses for the acquisition of theatre properties and equipment [2]         (3,536) 1,043
Investment in NCM – receipt of common units (see Note 9)         10,237 3,620
Adjustment to accrued dividends on unvested restricted stock unit awards   $ (2)   $ (256) 2 (256)
NCM            
Noncash investing and financing activities:            
Interest expense - NCM (see Note 9) $ (5,962)   $ (5,934)   $ (11,797) $ (11,825)
[1] Represents cash deposited in a collateral account during the period to support the issuance of letters of credit to lenders.  See further discussion at Note 7.
[2] Additions to theatre properties and equipment included in accounts payable as of June 30, 2021 and December 31, 2020 were $24,714 and $28,250, respectively.
[3] On March 20, 2020 the Company paid a $0.36 dividend per common share to stockholders of record on March 6, 2020.  Additionally, the Company accrued dividends on outstanding unvested restricted stock units.